Assignee
CLEXIO BIOSCIENCES LTD
IL·36 granted patents·33 pending applications·89 citations·filing 2015–2025
Top patents by PatentIndex Score
69 records- 0196US11534409B2Immediate release abuse-deterrent granulated dosage formsCLEXIO BIOSCIENCES LTD·Filed 2021·Granted Dec 27, 2022·4 cites·19 claims
- 0295US11253487B2Method of treating major depressive disorderCLEXIO BIOSCIENCES LTD·Filed 2021·Granted Feb 22, 2022·14 cites·20 claims
- 0394US12016832B2Method of treating major depressive disorderCLEXIO BIOSCIENCES LTD·Filed 2022·Granted Jun 25, 2024·5 cites·20 claims
- 0494US11957645B2Method of treating major depressive disorderCLEXIO BIOSCIENCES LTD·Filed 2023·Granted Apr 16, 2024·4 cites·17 claims
- 0594US11207318B2Immediate release abuse-deterrent granulated dosage formsCLEXIO BIOSCIENCES LTD·Filed 2020·Granted Dec 28, 2021·3 cites·14 claims
- 0692US11865088B2Method of treating major depressive disorderCLEXIO BIOSCIENCES LTD·Filed 2019·Granted Jan 9, 2024·4 cites·17 claims
- 0792US11730702B2Immediate release abuse-deterrent granulated dosage formsCLEXIO BIOSCIENCES LTD·Filed 2020·Granted Aug 22, 2023·2 cites·20 claims
- 0891US11903928B2Methods of treating pruritusCLEXIO BIOSCIENCES LTD·Filed 2021·Granted Feb 20, 2024·2 cites·20 claims
- 0991US10888528B2Immediate release abuse-deterrent granulated dosage formsCLEXIO BIOSCIENCES LTD·Filed 2019·Granted Jan 12, 2021·3 cites·19 claims
- 1091US10568881B2Immediate release abuse-deterrent granulated dosage formsCLEXIO BIOSCIENCES LTD·Filed 2018·Granted Feb 25, 2020·7 cites·23 claims
- 1191US10195143B2Devices and methods for preparing gastroretentive dosage formsCLEXIO BIOSCIENCES LTD·Filed 2016·Granted Feb 5, 2019·9 cites·26 claims
- 1290US11185532B2Methods of treating pruritusCLEXIO BIOSCIENCES LTD·Filed 2020·Granted Nov 30, 2021·3 cites·20 claims
- 1389US10485758B2Expandable gastroretentive dosage formCLEXIO BIOSCIENCES LTD·Filed 2015·Granted Nov 26, 2019·11 cites·62 claims
- 1487US11324707B2Abuse-deterrent dosage forms containing esketamineCLEXIO BIOSCIENCES LTD·Filed 2020·Granted May 10, 2022·3 cites·19 claims
- 1587US11147766B2Gastric retentive devicesCLEXIO BIOSCIENCES LTD·Filed 2016·Granted Oct 19, 2021·4 cites·20 claims
- 1685US12336970B2Method of treating major depressive disorderCLEXIO BIOSCIENCES LTD·Filed 2023·Granted Jun 24, 2025·0 cites·16 claims
- 1785US12280022B2Method of treating major depressive disorderCLEXIO BIOSCIENCES LTD·Filed 2023·Granted Apr 22, 2025·0 cites·20 claims
- 1885US12076300B2Dosage regime with esketamine for treating major depressive disorderCLEXIO BIOSCIENCES LTD·Filed 2023·Granted Sep 3, 2024·1 cites·5 claims
- 1984US12514831B2Method of treating major depressive disorderCLEXIO BIOSCIENCES LTD·Filed 2023·Granted Jan 6, 2026·0 cites·9 claims
- 2084US12268658B2Dosage regime with esketamine for treating major depressive disorderCLEXIO BIOSCIENCES LTD·Filed 2020·Granted Apr 8, 2025·2 cites·19 claims
- 2184US11285102B2Expandable gastroretentive dosage formCLEXIO BIOSCIENCES LTD·Filed 2019·Granted Mar 29, 2022·1 cites·19 claims
- 2284US2023293445A1Immediate release abuse-deterrent granulated dosage formsCLEXIO BIOSCIENCES LTD·Filed 2023·Application pending·0 cites
- 2384US2026021058A1Esketamine for use in treating major depressive disorderCLEXIO BIOSCIENCES LTD·Filed 2025·Application pending·0 cites
- 2483US2025281428A1Method Of Treating Major Depressive DisorderCLEXIO BIOSCIENCES LTD·Filed 2025·Application pending·0 cites
- 2581US12239634B2Methods of treating pruritusCLEXIO BIOSCIENCES LTD·Filed 2023·Granted Mar 4, 2025·0 cites·20 claims
- 2680US12036189B2Method of treating major depressive disorderCLEXIO BIOSCIENCES LTD·Filed 2019·Granted Jul 16, 2024·3 cites·17 claims
- 2780US11844796B2Immediate release abuse-deterrent granulated dosage formsCLEXIO BIOSCIENCES LTD·Filed 2021·Granted Dec 19, 2023·0 cites·17 claims
- 2879US2025195454A1Method of treating major depressive disorderCLEXIO BIOSCIENCES LTD·Filed 2025·Application pending·0 cites
- 2978US2026053757A1Dosage regime with esketamine for treating neuropsychiatric or neurological conditionsCLEXIO BIOSCIENCES LTD·Filed 2025·Application pending·0 cites
- 3076US2022202709A1Expandable gastroretentive dosage formCLEXIO BIOSCIENCES LTD·Filed 2021·Application pending·0 cites
- 3175US2022160630A1Expandable gastroretentive dosage formCLEXIO BIOSCIENCES LTD·Filed 2021·Application pending·0 cites
- 3275US2022211617A1Expandable gastroretentive dosage formCLEXIO BIOSCIENCES LTD·Filed 2021·Application pending·0 cites
- 3375US2025312293A1Esketamine for use in treating major depressive disorderCLEXIO BIOSCIENCES LTD·Filed 2025·Application pending·0 cites
- 3474US11547839B2Long acting gastric residence systemCLEXIO BIOSCIENCES LTD·Filed 2018·Granted Jan 10, 2023·2 cites·10 claims
- 3574US10737079B2Gastric residence systemCLEXIO BIOSCIENCES LTD·Filed 2017·Granted Aug 11, 2020·2 cites·37 claims
- 3673US2022202708A1Expandable gastroretentive dosage formCLEXIO BIOSCIENCES LTD·Filed 2021·Application pending·0 cites
- 3772US11648198B2Expandable gastroretentive dosage formCLEXIO BIOSCIENCES LTD·Filed 2020·Granted May 16, 2023·0 cites·15 claims
- 3872US2024374539A1Dosage regime with esketamine for treating major depressive disorderCLEXIO BIOSCIENCES LTD·Filed 2024·Application pending·0 cites
- 3971US12364672B2Esketamine for use in treating major depressive disorderCLEXIO BIOSCIENCES LTD·Filed 2019·Granted Jul 22, 2025·0 cites·15 claims
- 4070US11992468B2Abuse-deterrent dosage forms containing esketamineCLEXIO BIOSCIENCES LTD·Filed 2023·Granted May 28, 2024·0 cites·8 claims
- 4169US11964120B2Long acting gastric residence systemCLEXIO BIOSCIENCES LTD·Filed 2022·Granted Apr 23, 2024·0 cites·12 claims
- 4268US12589083B2Abuse-deterrent dosage forms containing esketamineCLEXIO BIOSCIENCES LTD·Filed 2021·Granted Mar 31, 2026·0 cites·11 claims
- 4368US2022370347A1Treatment of nocturnal symptoms and morning akinesia in subjects with parkinson's diseaseCLEXIO BIOSCIENCES LTD·Filed 2022·Application pending·0 cites
- 4467US2024366530A1Method of treating major depressive disorderCLEXIO BIOSCIENCES LTD·Filed 2024·Application pending·0 cites
- 4565US12478592B2Dosage regime with esketamine for treating neuropsychiatric or neurological conditionsCLEXIO BIOSCIENCES LTD·Filed 2020·Granted Nov 25, 2025·0 cites·16 claims
- 4665US10406154B2Transdermal dosage formCLEXIO BIOSCIENCES LTD·Filed 2018·Granted Sep 10, 2019·0 cites·27 claims
- 4765US2023398098A1Topical detomidine formulationsCLEXIO BIOSCIENCES LTD·Filed 2023·Application pending·0 cites
- 4865US2023080008A1Gastric residence systemCLEXIO BIOSCIENCES LTD·Filed 2022·Application pending·0 cites
- 4964US2025082587A1Method Of Treating Major Depressive DisorderCLEXIO BIOSCIENCES LTD·Filed 2024·Application pending·0 cites
- 5064US2019343830A1Transdermal dosage formCLEXIO BIOSCIENCES LTD·Filed 2019·Application pending·0 cites
Showing the top 50 of 69 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →